Antibiotice Iasi Ends Jan-Sept 2024 with RON511M Revenues, Up 7%. Net Profit Rises 15% To RON88M
<img src="http://storage0.dms.mpinteractiv.ro/media/401/1561/19649/22557247/1/grafic-generic-3.jpg?width=160&height=120"/> Romanian drug manufacturer Antibiotice Iasi, in which the Romanian state hold 53%, registered RON511 million revenues in the first nine months of 2024, up 15% annually, while net profit went up by 15% to RON88 million.
														<br/><br/><a href="https://core.adservingfactory.com/click?spgid=0&__x1ts=&pub=62&site=4268&section=0&zone=2008&size=0x0&__x1cguid=450">
					<img src="https://core.adservingfactory.com/ad?__x1ns=1&spgid=0&pub=632203491294404&site=rss.zf&section=site&zone=RSS_feed&size=300x250&__x1cguid=450" border="0" alt=""/>
					</a>